New Data Reveals The Financial Impact Of The Pandemic On Holidays
Latest data from trivago shows a real appetite from travellers to make 2022 ‘the best summer ever’
New data from trivago (using One Poll) reveals that travel restrictions during the pandemic saved would-be travellers an average of £1887.70, with almost one-in-ten (8%) saying they saved over £5000. When asked what they have done with the money, 45% said they put it in a savings account, 22% treated themselves, 20% put it towards a large purchase and 19% put it towards rent or a deposit for a house.
As travel restrictions finally lift, the appetite to travel is recovering strongly. Of those who generally have at least one holiday a year, a third (33%) have already made firm plans to travel in 2022 and a further 21% have made tentative plans. In total, over a third (34%) say they have been browsing/investigating future holidays more than before the pandemic.
The pandemic has also increased Brits willingness to spend more on their travel habits - almost four-in-ten (37%) travellers plan on spending more on their holidays. This rises to two-thirds (66%) of 18- to 24-year-olds. Where travellers reside has a marked impact in spending. Whilst over half (55%) of Londoners are planning on spending more on their holidays this year, only 20% of travellers from East Anglia are willing to dig deeper into their wallet. In total, it is the over 65s who remain the most cautious, with 18% saying they will likely spend less than if the pandemic hadn’t happened.
However, despite Brits saving money by being unable to travel during the pandemic, wannabe travellers are still more concerned about their finances than their health. In fact, the research revealed that 48% of UK travellers would make concrete plans if they could guarantee their money back should they get their holiday cancelled, compared with 33% who said they would be more likely to book if there was a guaranteed low risk of catching Covid-19.
Percentage of travellers willing to spend more on their holiday than they would have done pre-pandemic, by region:
|East Anglia||East Midlands||London||North East||North West||Northern Ireland||Scotland||South East||South West||Wales||West Midlands||Yorkshire and the Humber|
|A little more||17%||22%||31%||31%||26%||41%||20%||32%||25%||26%||28%||17%|
“Expectations are high that this could be the best summer ever. Of those who have firm plans to travel, over half (51%) believe that 2022 is going to be their best summer yet for travel,” comments Axel Hefer, CEO of trivago. “Travellers are tired of waiting for a dream getaway. Three-in-ten (30%) told us they are planning on organising a ‘bucket list' holiday sooner than originally thought due to the pandemic.”
Notes to Editors:
The survey was deployed online and ran from February 25-March 3, 2022 polling a sample of 2,000 adults age 18+ in both countries for a total of 4,000 respondents. For both countries, quotas were used to ensure an accurate representation of each countries’ population by gender, age, geographic region, education, and income.
trivago is a leading global hotel search platform focused on reshaping the way travelers search for and compare hotels and alternative accommodations. Incorporated in 2005 in Düsseldorf, Germany, the platform allows travelers to make informed decisions by personalizing their hotel search and providing them access to a deep supply of hotel information and prices. trivago enables its advertisers to grow their businesses by providing access to a broad audience of travelers via its websites and apps.
Press Contact: Trivago Unity Team firstname.lastname@example.org
This press release contains certain forward-looking statements. Words, and variations of words such as “believe,” “expect,” “plan,” “continue,” “will,” “should,” and similar expressions are intended to identify our forward-looking statements. These forward-looking statements involve risks and uncertainties, many of which are beyond our control, and important factors that could cause actual events and results to differ materially from those in the forward-looking statements. For additional information factors that could affect our forward-looking statements, see our risk factors, as they may be amended from time to time, set forth in our public filings with the Securities and Exchange Commission. We disclaim and do not undertake any obligation to update or revise any forward-looking statement in this press release, except as required by applicable law or regulation.To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Change in Aspo’s Group Executive Committee27.6.2022 10:20:00 CEST | Press release
Aspo Plc Stock exchange release June 27, 2022 at 11:20 a.m. Change in Aspo’s Group Executive Committee Heli Arantola, Managing Director of Aspo’s subsidiary Leipurin, has resigned to join another company. Arantola will leave the company in December at the latest, and the process of selecting her successor has begun. “I thank Heli for her excellent contribution to the modernization of Leipurin and transforming the company in the rapidly changing bakery and food industry. I wish her the best of luck in her future endeavors,” says Rolf Jansson, CEO of Aspo Group. Aspo Plc Rolf Jansson CEO Further information, please contact: Rolf Jansson, CEO, Aspo Plc, +358 400 600 264, email@example.com DISTRIBUTION: Nasdaq Helsinki Key media www.aspo.com Aspo creates value by owning and developing business operations sustainably and in the long term. Our companies aim to be market leaders in their sectors. They are responsible for their own operations, customer relationships and the development of
Cool Company Ltd. – Mandatory Notification Of Trade27.6.2022 10:17:48 CEST | Press release
EPS Ventures Ltd., close associate of Cyril Ducau, Chair of the Board of Cool Company Ltd. (the “Company”), has on 24 June 2022 acquired 7,035 shares in the Company at a price of NOK 89.307527 per share. Following the transaction, EPS Ventures Ltd. holds a total of 15,598,523 shares in the Company, equivalent to 38.99% of the Company’s shares. Please see attached notification form in accordance with the Market Abuse Regulation article 19. This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act Attachment Primary insider notification form
Scandinavian Tobacco Group A/S: Transactions in connection with share buy-back programme27.6.2022 08:45:00 CEST | Press release
Company Announcement No. 43/2022 Copenhagen, 27 June 2022 Transactions in connection with share buy-back programme On 19 May 2022, Scandinavian Tobacco Group A/S announced that the share buy-back programme that was initiated 9 March 2022 was increased to an aggregated value of up to DKK 1,000 million. The purpose of the programme is to adjust the Company’s capital structure and meet obligations relating to the Group’s share-based incentive programme. Part of the buy-back programme is executed in accordance with Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (the “Market Abuse Regulation”) and Commission Delegated Regulation (EU) 2016/1052, also referred to as the Safe Harbour rules. Another part of the share buy-back programme is conducted as a directed buy-back from Chr. Augustinus Fabrikker Aktieselskab and C.W. Obel A/S as further described in company announcement no. 35/2022. The share buy-back programme will end no later than 28 February 2023. The
Basilea reports progress on the implementation of its strategy to focus on anti-infectives27.6.2022 07:15:00 CEST | Press release
ERADICATE phase 3 study exploring ceftobiprole for the treatment of patients with Staphylococcus aureus bacteremia (SAB) expected to report results shortlySeparate transactions for TTK/PLK1 inhibitor (BAL0891) and preclinical oncology projects expected to be concluded in H2 2022 No expansion of ongoing lisavanbulin clinical studies; exploring partnering opportunitiesDerazantinib rights to be transferred back to Merck & Co. by the end of 2022No material expenses related to oncology activities beyond 2022 and sustainable profitability expected in 2023Strategy implementation on track Ad hoc announcement pursuant to Art. 53 LR Basel/Allschwil, Switzerland, June 27, 2022 Basilea Pharmaceutica Ltd (SIX: BSLN), a commercial-stage biopharmaceutical company, announced today an update on the progress made in the implementation of its strategic focus on anti-infectives. David Veitch, Chief Executive Officer, stated: “We have made significant progress in the implementation of our new strategy. Wit
Report – ERYTECH’s Combined Shareholders’ Meeting On June 24, 202224.6.2022 22:05:00 CEST | Press release
REPORT –ERYTECH’S COMBINED SHAREHOLDERS’ MEETING ON JUNE 24, 2022 Cambridge, MA (U.S.) and Lyon (France), June24, 2022 – ERYTECH Pharma (Nasdaq& Euronext: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, today announcedthat its Annual General Meeting was held on Friday, June 24, 2022. At the meeting, all resolutions for which the Board of Directors recommended a vote in favor were adopted, including: Approval of the annual financial statements and consolidated financial statements for the year ended December 31, 2021;Allocation of the financial year's results;Approval of the statutory auditors’ special report on regulated agreements and commitments with related parties;Approval of the elements of total compensation and benefits paid or allocated for the year ended December 31, 2021, to Gil BEYEN, Chief Executive Officer and Jean-Paul KRESS, Chairman of the Board;Approval of the compens